Translational Medicine
Greater New York City Area
- Current
-
- Assoc. Director, Translational Medicine at Regeneron Pharmaceuticals, Inc.
- Past
-
- Director, Preclinical & Translational Oncology at Novacea
- Staff Research Scientist III, Dept. Preclinical Oncology at Cell Genesys, Inc.
- Education
-
- University of California, San Francisco - School of Medicine and Howard Hughes Medical Institute
- University of Alberta
- The University of Calgary
- Connections
-
200
connections
- Industry
- Biotechnology
- Websites
Alshad S. Lalani’s Summary
Preclinical and Translational Cancer Research and Oncology Drug Development. Business Development and Licensing Evaluation for Novel Therapeutic Agents in Oncology.
Alshad S. Lalani’s Experience
-
Assoc. Director, Translational Medicine
Regeneron Pharmaceuticals, Inc.
(Privately Held; 501-1000 employees; REGN; Biotechnology industry)
March 2008 — Present (1 year 9 months)
-
Director, Preclinical & Translational Oncology
Novacea
(Public Company; 11-50 employees; NOVC; Biotechnology industry)
October 2005 — March 2008 (2 years 6 months)
-
Staff Research Scientist III, Dept. Preclinical Oncology
Cell Genesys, Inc.
(Public Company; 201-500 employees; CEGE; Biotechnology industry)
August 2000 — June 2005 (4 years 11 months)
Alshad S. Lalani’s Education
-
University of California, San Francisco - School of Medicine and Howard Hughes Medical Institute
Post-doctoral Fellowship , Virology and Pathogenesis; Microbiology and Immunology; KSHV & AIDS-related malignancies , 1999 — 2000
-
University of Alberta
Ph.D. , Biochemistry, Viral Immunology & Pathogenesis , 1993 — 1999
-
The University of Calgary
B.Sc. , Cellular, Molecular and Microbial Biology , 1987 — 1991
Additional Information
Alshad S. Lalani’s Websites:
Alshad S. Lalani’s Groups:
American Society of Clinical Oncology
American Association for Cancer Research
American Association for Advancement of Science
American Society for Hematology
-
Licensing Executives Society (LES), Silicon Valley Chapter (SVC)
